Public health experts are raising alarms after U.S. vaccine advisers moved to scale back long-standing recommendations for hepatitis B immunization in newborns, a decision they say could reverse decades of progress in preventing a serious and potentially life-threatening infection. For more than 30 years, U.S. health authorities have advised that all infants receive a hepatitis… Continue reading Experts Warn Rollback of Hepatitis B Guidance Could Weaken Disease Prevention in the U.S.
Data-driven market news & analysis